Malvanese Williams, | |
809 College St, Shreveport, LA 71104-2928 | |
(318) 658-6099 | |
Not Available |
Full Name | Malvanese Williams |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 809 College St, Shreveport, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003288903 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Malvanese Williams, 809 College St, Shreveport, LA 71104-2928 Ph: (318) 658-6099 | Malvanese Williams, 809 College St, Shreveport, LA 71104-2928 Ph: (318) 658-6099 |
News Archive
Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer Center.
People's ethnicity impacts their physical activity following a kidney transplant, according to research carried out by the University of Leicester.
Pregnant women are an important but thus far largely overlooked group vulnerable to the effects of extreme heat linked to climate change, according to new research by Sabrina McCormick, Ph.D., an Associate Professor of Environmental and Occupational Health at Milken Institute School of Public Health at the George Washington University.
Medtronic, today announced it has received conditional approval from the U.S. Food and Drug Administration to modify its CoreValve U.S. Pivotal Clinical Trial.
› Verified 9 days ago